Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.

Gebbia, V; Testa, A; Valenza, R; Cannata, G; Tirrito, M L; Gebbia, N

Gebbia, V; Testa, A; Valenza, R; Cannata, G; Tirrito, M L; Gebbia, N.

Affiliation

Gebbia V; Service of Chemotherapy, Institute of Pharmacology, University of Palermo, Italy.

Cancer ; 76(10): 1821-8, 1995 Nov 15.

Article in En | MEDLINE | ID: mdl-8625054

Subject(s)

Antiemetics/administration & dosage; Cisplatin/adverse effects; Granisetron/administration & dosage; Methylprednisolone/administration & dosage; Metoclopramide/administration & dosage; Nausea/prevention & control; Neoplasms/drug therapy; Vomiting/prevention & control; Administration, Oral; Adult; Aged; Drug Therapy, Combination; Female; Granisetron/adverse effects; Humans; Male; Methylprednisolone/adverse effects; Metoclopramide/adverse effects; Middle Aged; Nausea/chemically induced; Prospective Studies; Vomiting/chemically induced

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vomiting / Methylprednisolone / Cisplatin / Granisetron / Metoclopramide / Antiemetics / Nausea / Neoplasms Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 1995 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links